strataoncology.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $128.35MM
Strata Oncology is a precision oncology company dedicated to delivering the best possible treatment for each patient with cancer.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/28/2021 | Series A-4 | $5.08MM | $xx.xx | $561.3MM | Arboretum Ventures, Baird Capital, Cormorant Asset Management, Deerfield Management, Highside Capital Management, Merck Global Health Innovation Fund, Monashee Investment Management, Pfizer Ventures, Renaissance Venture Capital, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
171,358
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Arboretum Ventures, Baird Capital, Cormorant Asset Management, Deerfield Management, Highside Capital Management, Merck Global Health Innovation Fund, Monashee Investment Management, Pfizer Ventures, Renaissance Venture Capital, Wellington Management
|
||||||
07/28/2021 | Series A-3 | $84.92MM | $xx.xx | $561.3MM | Arboretum Ventures, Baird Capital, Cormorant Asset Management, Deerfield Management, Highside Capital Management, Merck Global Health Innovation Fund, Monashee Investment Management, Pfizer Ventures, Renaissance Venture Capital, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
2,434,429
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Arboretum Ventures, Baird Capital, Cormorant Asset Management, Deerfield Management, Highside Capital Management, Merck Global Health Innovation Fund, Monashee Investment Management, Pfizer Ventures, Renaissance Venture Capital, Wellington Management
|
||||||
05/01/2018 | Series A-2 | $26MM | $xx.xx | $86.53MM | Arboretum Ventures, Baird Capital, Deerfield Management, Merck Global Health Innovation Fund, Pfizer Ventures, Renaissance Venture Capital | |
Price per Share
$xx.xx
Shares Outstanding
3,938,877
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Arboretum Ventures, Baird Capital, Deerfield Management, Merck Global Health Innovation Fund, Pfizer Ventures, Renaissance Venture Capital
|
||||||
06/02/2016 | Series A-1 | $12.34MM | $xx.xx | $22.45MM | Arboretum Ventures, Baird Capital, Michigan Elab | |
Price per Share
$xx.xx
Shares Outstanding
4,579,011
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Arboretum Ventures, Baird Capital, Michigan Elab
|